Response to Krieger et al. re: “TSHR/IGF-1R Cross-Talk, Not IGF-1R Stimulating Antibodies, Mediates Graves' Ophthalmopathy Pathogenesis” (Thyroid 2017;27:746–747)
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.